- Home
- SCLX vs KIRK Comparison
SCLX vs KIRK Comparison
Compare SCLX & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- KIRK
- Stock Information
- Founded
- SCLX 2011
- KIRK 1966
- Country
- SCLX United States
- KIRK United States
- Employees
- SCLX N/A
- KIRK N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- KIRK Diversified Commercial Services
- Sector
- SCLX Health Care
- KIRK Miscellaneous
- Exchange
- SCLX Nasdaq
- KIRK Nasdaq
- Market Cap
- SCLX 35.7M
- KIRK 33.5M
- IPO Year
- SCLX N/A
- KIRK 2002
- Fundamental
- Price
- SCLX $13.63
- KIRK $1.66
- Analyst Decision
- SCLX Strong Buy
- KIRK Buy
- Analyst Count
- SCLX 3
- KIRK 2
- Target Price
- SCLX $367.50
- KIRK $4.50
- AVG Volume (30 Days)
- SCLX 225.6K
- KIRK 503.8K
- Earning Date
- SCLX 08-12-2025
- KIRK 09-04-2025
- Dividend Yield
- SCLX N/A
- KIRK N/A
- EPS Growth
- SCLX N/A
- KIRK N/A
- EPS
- SCLX N/A
- KIRK N/A
- Revenue
- SCLX $50,710,000.00
- KIRK $431,111,000.00
- Revenue This Year
- SCLX $68.30
- KIRK N/A
- Revenue Next Year
- SCLX $124.48
- KIRK N/A
- P/E Ratio
- SCLX N/A
- KIRK N/A
- Revenue Growth
- SCLX 7.79
- KIRK N/A
- 52 Week Low
- SCLX $3.60
- KIRK $1.05
- 52 Week High
- SCLX $57.75
- KIRK $2.50
- Technical
- Relative Strength Index (RSI)
- SCLX 65.59
- KIRK 49.67
- Support Level
- SCLX $10.14
- KIRK $1.48
- Resistance Level
- SCLX $17.76
- KIRK $1.73
- Average True Range (ATR)
- SCLX 1.79
- KIRK 0.19
- MACD
- SCLX 0.52
- KIRK 0.00
- Stochastic Oscillator
- SCLX 57.45
- KIRK 17.69
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.